SIMCERE PHARMAC. GRP LTD (S2P) — Cash Flow Reinvestment Rate
SIMCERE PHARMAC. GRP LTD (S2P) has a Cash Flow Reinvestment Rate of 0.69x as of December 2025, reinvesting €1.39 Billion (capex €862.20 Million plus investments €-524.90 Million) from operating cash flow of €2.01 Billion. Explore SIMCERE PHARMAC. GRP LTD (S2P) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
SIMCERE PHARMAC. GRP LTD Cash Flow Reinvestment Rate (2022–2025)
Historical reinvestment intensity for SIMCERE PHARMAC. GRP LTD across 4 annual periods. Also explore SIMCERE PHARMAC. GRP LTD total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for SIMCERE PHARMAC. GRP LTD (2022–2025)
Year-by-year capital reinvestment analysis for SIMCERE PHARMAC. GRP LTD. For live market cap and broader valuation context, see SIMCERE PHARMAC. GRP LTD (S2P) total market value.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.69x | €1.39 Billion | €2.01 Billion | €862.20 Million | ▼ -24.3% |
| 2024 | 0.91x | €1.27 Billion | €1.39 Billion | €762.57 Million | ▼ -92.6% |
| 2023 | 12.32x | €1.86 Billion | €151.05 Million | €979.86 Million | ▲ +1340.9% |
| 2022 | 0.85x | €1.16 Billion | €1.35 Billion | €678.00 Million | — |